EA201691306A1 - Пептидные комбинации и их применение при лечении аллергии на клещей домашней пыли - Google Patents

Пептидные комбинации и их применение при лечении аллергии на клещей домашней пыли

Info

Publication number
EA201691306A1
EA201691306A1 EA201691306A EA201691306A EA201691306A1 EA 201691306 A1 EA201691306 A1 EA 201691306A1 EA 201691306 A EA201691306 A EA 201691306A EA 201691306 A EA201691306 A EA 201691306A EA 201691306 A1 EA201691306 A1 EA 201691306A1
Authority
EA
Eurasian Patent Office
Prior art keywords
der
allergy
claw
treatment
peptides
Prior art date
Application number
EA201691306A
Other languages
English (en)
Inventor
Клаус Лундегорд
Ларс Хардер Кристенсен
Петер Адлер Вюртцен
Алессандро Сетте
Джон Сидни
Гитте Лунд
Original Assignee
Альк-Абелло А/С
Ла Хойя Инститьют Фор Эллерджи Энд Иммьюнолоджи
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Альк-Абелло А/С, Ла Хойя Инститьют Фор Эллерджи Энд Иммьюнолоджи filed Critical Альк-Абелло А/С
Publication of EA201691306A1 publication Critical patent/EA201691306A1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43531Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретение относится к комбинациям пептидов или их вариантов, полученных из части аминокислотной последовательности аллергена клеща домашней пыли, например аллергенов Der p 1, Der f 1, Der p 2 и/или Der f 2. Такие пептиды содержат по меньшей мере один Т-клеточный эпитоп, и значительно большое число пациентов в мировой популяции будет иметь аллели HLA с потенциалом связывания с пептидами пептидных комбинаций. Настоящее изобретение также относится к применению таких пептидных комбинаций при ослаблении иммунного ответа, вызываемого пылевыми клещами.
EA201691306A 2013-12-23 2014-12-23 Пептидные комбинации и их применение при лечении аллергии на клещей домашней пыли EA201691306A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361919925P 2013-12-23 2013-12-23
US201462012690P 2014-06-16 2014-06-16
PCT/US2014/072228 WO2015100360A1 (en) 2013-12-23 2014-12-23 Peptide combinations and uses thereof in treating dust mite allergy

Publications (1)

Publication Number Publication Date
EA201691306A1 true EA201691306A1 (ru) 2016-10-31

Family

ID=52293308

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201691306A EA201691306A1 (ru) 2013-12-23 2014-12-23 Пептидные комбинации и их применение при лечении аллергии на клещей домашней пыли

Country Status (12)

Country Link
US (1) US10059751B2 (ru)
EP (1) EP3086806B1 (ru)
JP (1) JP2017507906A (ru)
KR (1) KR20160096206A (ru)
CN (1) CN105848677B (ru)
AU (1) AU2014369866A1 (ru)
BR (1) BR112016011930A2 (ru)
CA (1) CA2933552A1 (ru)
EA (1) EA201691306A1 (ru)
MX (1) MX2016008305A (ru)
SG (1) SG11201604892YA (ru)
WO (1) WO2015100360A1 (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9265824B2 (en) * 2010-06-03 2016-02-23 Alk-Abello A/S Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof
US11013781B2 (en) 2015-07-01 2021-05-25 Alk-Abelló As Peptide combinations and uses thereof for treating grass allergy
US11464839B2 (en) 2015-12-04 2022-10-11 Mayo Foundation For Medical Education And Research Methods and vaccines for inducing immune responses to multiple different MHC molecules
WO2017203057A1 (en) * 2016-05-27 2017-11-30 Alk-Abelló A/S Immunogenic proteins and fragments thereof from allergenic mites
CN108265059B (zh) 2016-12-31 2021-01-05 江苏众红生物工程创药研究院有限公司 一种重组粉尘螨2类变应原蛋白及其制备方法与应用
CN107338261B (zh) * 2017-07-17 2023-04-07 海南大学 热带无爪螨重组变应原Blot5-21、其制备方法及过敏小鼠模型的建立
CA3133175A1 (en) * 2019-03-14 2020-09-17 Engene, Inc. Reversible coating of chitosan-nucleic acid nanoparticles and methods of their use
CN113125753B (zh) * 2021-04-16 2022-07-26 杭州浙大迪迅生物基因工程有限公司 一种用于检测尘螨组分特异性抗体的试剂盒

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
US7288256B1 (en) 1991-10-16 2007-10-30 Merck Patent Gmbh T cell epitopes of the major allergens from dermatophagoides (house dust mite)
WO1994024281A1 (en) 1993-04-14 1994-10-27 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
KR100271417B1 (ko) 1991-10-16 2000-12-01 스타세이 엘. 첸닝 재조합 펩티드
KR100379161B1 (ko) 1994-04-14 2003-06-11 이뮤로직 파마시티컬 코포레이션 집먼지진드기에의한알레르기를치료하기위한의학적펩티드조성물
US5968526A (en) * 1994-04-14 1999-10-19 Immulogic Pharamaceutical Corporation T cell epitopes of the major allergens from Dermatophagoides (house dust mite)
JP2001231563A (ja) 2000-02-18 2001-08-28 Asahi Breweries Ltd 改変したダニアレルゲン(システイン変異体)及びその製造方法
CA2546443A1 (en) 2003-11-18 2005-06-02 Nanopass Technologies Ltd. Enhanced penetration system and method for sliding microneedles
WO2006054280A2 (en) 2004-11-18 2006-05-26 Nanopass Technologies Ltd. System and method for delivering fluid into flexible biological barrier
CA2631882C (en) 2005-12-08 2015-02-10 Nanopass Technologies Ltd. Microneedle adapter for dosed drug delivery devices
DK2476436T3 (en) * 2006-08-11 2018-02-05 Life Sciences Res Partners Vzw Immunogenic peptides and their use in immune disorders
CA2696563A1 (en) * 2007-08-15 2009-02-19 Circassia Limited Peptides for vaccine
EP2331124A1 (en) * 2008-08-15 2011-06-15 Circassia Limited T-cell antigen peptide from allergen for stimulation of il-10 production
RU2630652C2 (ru) 2011-06-09 2017-09-11 Биомей Аг Гибридные белки-носители пептидов в качестве вакцин от аллергии
US20130110043A1 (en) 2011-10-26 2013-05-02 Nanopass Technologies Ltd. Microneedle Intradermal Drug Delivery Device with Auto-Disable Functionality
EP2812028A4 (en) * 2012-02-07 2016-01-06 Jolla Inst Allergy Immunolog EPITOPES OF ALLERGENIC PROTEINS AND METHOD AND USE TO IMMUNE REACTION MODULATION
IN2014MN01513A (ru) 2012-02-07 2015-09-11 Jolla Inst Allergy Immunolog
US20130302338A1 (en) 2012-05-14 2013-11-14 Promd Biotech. Co., Ltd. Dermatophagoid pteronyssinus (der p1) antigen epitope and anti-der p1 antibody
US20140350514A1 (en) 2013-05-22 2014-11-27 Nanopass Technologies Ltd. Systems and methods for intradermal delivery of therapeutics using microneedles

Also Published As

Publication number Publication date
WO2015100360A1 (en) 2015-07-02
KR20160096206A (ko) 2016-08-12
CA2933552A1 (en) 2015-07-02
EP3086806A1 (en) 2016-11-02
MX2016008305A (es) 2017-01-11
US10059751B2 (en) 2018-08-28
BR112016011930A2 (pt) 2017-09-26
CN105848677B (zh) 2020-01-31
JP2017507906A (ja) 2017-03-23
CN105848677A (zh) 2016-08-10
EP3086806B1 (en) 2019-12-11
AU2014369866A1 (en) 2016-06-30
US20160251403A1 (en) 2016-09-01
SG11201604892YA (en) 2016-07-28

Similar Documents

Publication Publication Date Title
EA201691306A1 (ru) Пептидные комбинации и их применение при лечении аллергии на клещей домашней пыли
AR125326A2 (es) Composiciones de neisseria meningitidis y métodos de las mismas
NZ715038A (en) T cell receptors
MX2020003260A (es) Anticuerpos asimetricos modificados que se unen al receptor fc y metodos de uso.
UA107212C2 (ru) Модификация мананазы
BR112016012358A2 (pt) peptídios terapêuticos
ATE482721T1 (de) Peptide zur desensibilisierung gegenüber allergenen
MX2015012872A (es) Anticuerpos anti-tau y metodos de uso.
EA201592264A1 (ru) Композиции, которые индуцируют хелперное действие т-клеток
UA118167C2 (uk) Пептид та його застосування
JP2015514395A5 (ru)
EA201491643A1 (ru) Идентификация мутаций канал-опсина-2 (chop2) и способы применения
GB201201511D0 (en) Modified epitopes for boosting CD4+ T-cell responses
MX346475B (es) Peptidos inmunogenicos monomericos y multimericos.
IN2014DN08325A (ru)
MX2014009285A (es) Alergenos del fleo de los prados y metodos y usos para la modulacion de respuesta inmune.
EA201171001A1 (ru) Пептиды трав для вакцины
WO2011123858A3 (en) Ccn3 peptides and analogs thereof for therapeutic use
EA201492068A1 (ru) Гидрохлоридная соль пептида и ее применение в комбинации с другими пептидами в иммунотерапии
MY193724A (en) Immune modulation
IN2014DN09445A (ru)
PH12015501033A1 (en) Peptides
MX2020012569A (es) Moleculas inmunoterapeuticas novedosas y sus usos.
WO2015086354A3 (en) Novel promiscuous hpv16-derived t helper epitopes for immunotherapy
MY169152A (en) Nutritional compositions containing a peptide component and uses thereof